» Articles » PMID: 29307118

Chemotherapy-induced Metastasis: Mechanisms and Translational Opportunities

Overview
Specialty Oncology
Date 2018 Jan 8
PMID 29307118
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

Tumors often overcome the cytotoxic effects of chemotherapy through either acquired or environment-mediated drug resistance. In addition, signals from the microenvironment obfuscate the beneficial effects of chemotherapy and may facilitate progression and metastatic dissemination. Seminal mediators in chemotherapy-induced metastasis appear to be a wide range of hematopoietic, mesenchymal and immune progenitor cells, originating from the bone marrow. The actual purpose of these cells is to orchestrate the repair response to the cytotoxic damage of chemotherapy. However, these repair responses are exploited by tumor cells at every step of the metastatic cascade, ranging from tumor cell invasion, intravasation and hematogenous dissemination to extravasation and effective colonization at the metastatic site. A better understanding of the mechanistic underpinnings of chemotherapy-induced metastasis will allow us to better predict which patients are more likely to exhibit pro-metastatic responses to chemotherapy and will help develop new therapeutic strategies to neutralize chemotherapy-driven prometastatic changes.

Citing Articles

Repurposing the anti-parasitic agent pentamidine for cancer therapy; a novel approach with promising anti-tumor properties.

Rastegar-Pouyani N, Farzin M, Zafari J, Haji Abdolvahab M, Hassani S J Transl Med. 2025; 23(1):258.

PMID: 40033361 PMC: 11877826. DOI: 10.1186/s12967-025-06293-w.


Pentagalloyl Glucose from Suppresses the Epithelial-Mesenchymal Transition and Synergizes the Doxorubicin-Induced Anticancer and Anti-Migration Effects in Triple-Negative Breast Cancer.

Kantapan J, Innuan P, Kongkarnka S, Sangthong P, Dechsupa N Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770571 PMC: 11679756. DOI: 10.3390/ph17121729.


Tubulin-Targeted Therapy in Melanoma Increases the Cell Migration Potential by Activation of the Actomyosin Cytoskeleton─An In Vitro Study.

Luty M, Szydlak R, Pabijan J, Zemla J, Oevreeide I, Prot V ACS Biomater Sci Eng. 2024; 10(11):7155-7166.

PMID: 39436192 PMC: 11558564. DOI: 10.1021/acsbiomaterials.4c01226.


Individualized evaluation of risk and prognosis in uterine leiomyosarcoma patients with synchronous distant metastases: a real-world retrospective study.

Liu Z, Gao F, Min T, Shang Q, Wang B, Pu J Front Oncol. 2024; 14:1417226.

PMID: 39386189 PMC: 11461169. DOI: 10.3389/fonc.2024.1417226.


A Review of the Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Nonhematologic Malignancies.

Koc D, Manescu I, Manescu M, Dobreanu M Diagnostics (Basel). 2024; 14(18).

PMID: 39335736 PMC: 11431542. DOI: 10.3390/diagnostics14182057.


References
1.
Volk-Draper L, Hall K, Griggs C, Rajput S, Kohio P, DeNardo D . Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner. Cancer Res. 2014; 74(19):5421-34. PMC: 4185415. DOI: 10.1158/0008-5472.CAN-14-0067. View

2.
Pignatelli J, Bravo-Cordero J, Roh-Johnson M, Gandhi S, Wang Y, Chen X . Macrophage-dependent tumor cell transendothelial migration is mediated by Notch1/Mena-initiated invadopodium formation. Sci Rep. 2016; 6:37874. PMC: 5129016. DOI: 10.1038/srep37874. View

3.
Wong R . Mesenchymal stem cells: angels or demons?. J Biomed Biotechnol. 2011; 2011:459510. PMC: 3142786. DOI: 10.1155/2011/459510. View

4.
Entenberg D, Wyckoff J, Gligorijevic B, Roussos E, Verkhusha V, Pollard J . Setup and use of a two-laser multiphoton microscope for multichannel intravital fluorescence imaging. Nat Protoc. 2011; 6(10):1500-20. PMC: 4028841. DOI: 10.1038/nprot.2011.376. View

5.
Mittal D, Saccheri F, Venereau E, Pusterla T, Bianchi M, Rescigno M . TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells. EMBO J. 2010; 29(13):2242-52. PMC: 2905255. DOI: 10.1038/emboj.2010.94. View